Articles related to PREVENTIVE MEDICINE

Current research on kombucha suggests potential benefits for gut health and blood sugar management, though human studies are limited. Physicians should be aware of its mild alcohol content and potential contraindications when discussing this beverage with patients.

Moderate caffeine intake (200-300 mg per day) was associated with a 40.7% lower risk of new-onset cardiometabolic multimorbidity compared to non-consumers or those consuming less than 100 mg daily.

Bempedoic acid reduced major adverse cardiovascular events by 13% compared to placebo in statin-intolerant patients, with efficacy comparable to statins when normalized for LDL-C reduction.

The Endocrine Society’s 2024 guidelines suggest against routine vitamin D screening and supplementation for most adults under 75, marking a significant shift in clinical practice recommendations.

A prospective study involving over 170,000 participants from the UK Biobank found that moderate coffee consumption (3 drinks/day) was associated with a 48.1% lower risk of developing cardiometabolic multimorbidity compared to non-consumers.

The PREVENT equation, developed by the American Heart Association in 2023, aims to provide a more accurate cardiovascular risk assessment for today’s population, potentially reducing statin prescriptions by 40%.